PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Etacrynate→

Etacrynate PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
6500-81-8
Molecular formula
C13H11Cl2NaO4
Molecular weight
325.12 g/mol
Drug class
Loop diureticethacrynic acid derivative
Mechanism of action
Ethacrynate sodium dissociates to ethacrynic acid, a loop diuretic that inhibits the Na-K-2Cl cotransporter in the thick ascending limb of the loop of Henle, reducing sodium and chloride reabsorption and increasing urinary excretion of sodium, chloride, potassium and water.
Indications / reported uses
  • Treatment of oedema associated with congestive heart failure, hepatic cirrhosis or renal disease, including nephrotic syndrome.
  • Intravenous use for acute pulmonary oedema or situations requiring rapid diuresis, under the product label.

Sources: https://www.dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e24e7440-a958-6fd0-6bfe-1bd29e638657 · https://www.ncbi.nlm.nih.gov/books/NBK557838/ · FDA product information

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Etacrynate PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Etacrynate Permitted Daily Exposure (PDE) report (the Etacrynate PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Etacrynate Occupational Exposure Limit (OEL) report (the Etacrynate OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.